SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-010326
Filing Date
2018-05-02
Accepted
2018-05-02 16:29:01
Documents
69
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adro-10q_20180331.htm 10-Q 2103337
2 EX-31.1 adro-ex311_7.htm EX-31.1 20226
3 EX-31.2 adro-ex312_8.htm EX-31.2 20101
4 EX-32.1 adro-ex321_6.htm EX-32.1 8311
  Complete submission text file 0001564590-18-010326.txt   8255096

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT adro-20180331.xml EX-101.INS 2025851
6 XBRL TAXONOMY EXTENSION SCHEMA adro-20180331.xsd EX-101.SCH 53454
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adro-20180331_cal.xml EX-101.CAL 55932
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adro-20180331_def.xml EX-101.DEF 175743
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE adro-20180331_lab.xml EX-101.LAB 420573
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adro-20180331_pre.xml EX-101.PRE 334470
Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 18800041
SIC: 2834 Pharmaceutical Preparations